Politics
Friday July 23, 2004
Pharmaceutical tries again for FDA Approval of Morning After Pill Without Prescription
TODAY'S HEADLINES
E-MAIL
PRINT
WASHINGTON, July 23, 2004 (LifeSiteNews.com) - This May, the Food and Drug Administration rejected nonprescription sales of emergency contraception, in the midst of controversy. Now the manufacturer of the abortifacient drug is again pressuring the US government to allow its sale without a prescription. The FDA decision left a loophole when they said they might reconsider if the company, Barr Pharmaceuticals, could show some way of guaranteeing that the drug will only be sold without prescription to girls and women over 16.
In their letter to Barr, the FDA said that there would have to be some means of selling the product as both a prescription-only and non-prescription drug and to educate the public as to the difference. The mixed marketing approach is called a 'novelty' in the letter and the FDA has never before approved such a scheme. A spokesman for Barr said that the legal counsel has found a way to comply with the FDA stipulations. "We are pleased to be responding to the FDA with a submission that we believe will lead to approval of use of Plan B emergency contraceptive as an over-the-counter product for women 16 and older will maintain the availability of Plan B as a prescription-only product for women age 15 years and younger," said Dr. Carole Ben-Maimon, President and COO of Barr Research.
ph
Back to TopLatest Headlines
- Cardinal Rigali: You Can't Claim to be "Reducing Abortions" but Publicly Funding them in D.C.
- General Electric to Use Embryonic Stem Cells for Testing, Phase out Lab Rats
- Ohio Supreme Court Allows Planned Parenthood to Conceal Abortion Records in Sexual Abuse Case
- LifeSiteNews Canada Day and Independence Day Message. Taking a few days off. LSN returns Monday July 6
- Heroically Pro-Life Brazilian Archbishop's Resignation Accepted Under Cloud of Vatican Newspaper Misrepresentation
- Pro-Life Groups Announce New Colorado Personhood Initiative
- Judge Puts Kibosh on DC Gay "Marriage" Referendum
- Al Franken Win Hands Supermajority to Senate Democrats
- Group Funded by Canadian Bishops' D&P Joins with Others to Denounce the "Natural Family" and "Family Rights"
- Financially Troubled Planned Parenthood of El Paso Closes Doors
- Abortion Linked to Subsequent Pre-Term Births, New Research Again Confirms
- New Orleans Homosexual Couple Ask Fed. Court to Overturn Marriage Amendment
- Slim Hope Of New Ontario Progressive Conservative Party Leader Promoting Pro-Life, Pro-Family Issues
- Pope Accepts Resignation of Bishop Caught Involved in Homosexual Encounters
- Young Children Removed from UK Schools for "Inappropriate Sexual Behaviour"
- Northern Ireland Politician Cleared of Wrongdoing after Reiterating Christian Teaching on Homosexual Acts
- UK Conservative Leader Speaks at Gay Pride Fundraiser
- More Letters to the Editor on Canadian Catholic Development and Peace Scandal (July 1)
- Letters to the Editor - Readers Respond to Development and Peace Scandal
- Watch This Dramatic New Video on Catholic Bishops Conference Funding of Pro-Abortion Groups
Most Read this Week
- Homosexual Duke U. Director Charged with Offering Adopted 5-Year-Old for Sex
- Famed Fr. Corapi Calls Canadian Bishops' Dissent from Humanae Vitae "Catastrophic"
- Pope: It is a Childish Faith to Oppose the Church Teaching on Life and Family
- LifeSiteNews Detailed Response to Canadian Bishops' Whitewash Report on Development and Peace
- Heroically Pro-Life Brazilian Archbishop's Resignation Accepted Under Cloud of Vatican Newspaper Misrepresentation
- Young Children Removed from UK Schools for "Inappropriate Sexual Behaviour"
- Is Pro-Choice the New Pro-Life?
- General Electric to Use Embryonic Stem Cells for Testing, Phase Out Lab Rats
- Swedish Parents Won't Tell if Child is Boy or Girl as Gender Experiment
- Cardinal Rigali: You Can't Claim to be "Reducing Abortions" but Publicly Funding them in D.C.
MORE NEWS: 
LifeSiteNews.com Home Page Last 10 Days Archives Special Reports
Copyright © LifeSiteNews.com. This work is licensed under a Creative Commons Attribution-No Derivatives License. You may republish this article or portions of it without request provided the content is not altered and it is clearly attributed to "LifeSiteNews.com". Any website publishing of complete or large portions of original LifeSiteNews articles MUST additionally include a live link to www.LifeSiteNews.com. The link is not required for excerpts. Republishing of articles on LifeSiteNews.com from other sources as noted is subject to the conditions of those sources.